Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes

May.13.2025
Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes
Itsuwa Technology (NEEQ: 833767) released its 2024 annual report, reporting revenue of 283 million yuan, down 12.59% year-on-year, and a net loss of 19.66 million yuan, a 194.47% decline from the previous year. The company attributed the loss to intense competition and product homogeneity in overseas markets, as well as rising labor costs. Its gross profit margin dropped to 30%, while R&D spending accounted for 9.12% of revenue. Going forward, the company plans to focus on developing eco-friendl

Recently, Itsuwa Co., Ltd. (NEEQ: 833767) in Shenzhen released its annual report for the year 2024. The report reveals that the company achieved a total operating income of 283 million yuan in 2024, a decrease of 12.59% compared to the previous year. The net profit attributable to the listed company's shareholders was -19.66 million yuan, a significant decrease of 194.47% year-on-year.

 

Itsuwa Posts 194% Drop in 2024 Net Profit with $2.7M Loss, to Focus on Modular and Eco-Friendly E-Cigarettes
Itsuwa's 2024 financial report | Image source: Itsuwa

 

In the report, Itsuwa explained that the main reason for the decline in performance is the intense competition in the overseas e-cigarette market for homogenized products. Similar products are sold at lower prices in the market, and the company's differentiated advantages are not obvious, leading to a decrease in sales revenue. Additionally, the product structure of the company is more complex than the previous year, causing an increase in the use of labor hours per unit product, resulting in an increase in labor costs that further compress the profit margin. In 2024, the company's main business gross profit margin was 30.00%, a decrease of 5.99 percentage points from the previous year's 35.99%.

 

Itsuwa has stated that the company will continue to increase its research and development investment, with R&D spending accounting for 9.12% of current operating income in 2024. Research and development products include disposable e-cigarettes, pod-based e-cigarettes, open systems, and the research emphasis is on environmental protection, compliance, modularity, multiple pods, high capacity, and enhanced customer experience. During the reporting period, the company held 135 valid patents, including 8 invention patents.

 

At the same time, the company actively promotes its own brands of e-cigarettes, such as VAPESOUL and VOOM, targeting different consumer groups. During the reporting period, sales of the company's own brand products accounted for 29.37% of total sales, and it plans to continue expanding sales of its own brand e-cigarettes through 2025.

 

The report highlights that global regulations on the e-cigarette market are becoming stricter, with many countries implementing policies and tax standards to control e-cigarettes.

 

Meanwhile, the environmental issues brought by disposable e-cigarettes are increasingly receiving attention. Domestic e-cigarette policies are also becoming more complete, with measures such as market access permits and total quantity management expected to promote supply-demand balance. Overall, the industry is fiercely competitive, and businesses face growing challenges.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana Halts Sales of Elf Bar, Lost Mary, MR FOG and iJOY Vapes Under Foreign-Adversary Rules; Some Products Return After Compliance Filings
Indiana's Alcohol and Tobacco Commission (ATC) ordered tobacco certificate holders in September to remove certain vaping products marketed under Elf Bar, Lost Mary, MR FOG, iJOY and other brands from inventory under the state's foreign-adversary product law. The agency later listed 257 MR FOG products and 77 Lost Mary product entries as lawful for sale. The Lost Mary revision expressly stated that compliance evidence had been received for 20 additional products. 2Firsts compliance expert Kurt said potential filings could include e-liquid and ingredient-origin records, U.S. nicotine-analog supply-chain documentation and FDA premarket application status.
Regulations
Oct.08
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
German Tobacco Tax Revenue Falls 10.8% Through August as Tax-Paid Cigarette Volume Drops 12.6%
Germany collected €9.789 billion in total tobacco tax revenue from January through August 2026, down 10.8% from a year earlier, according to the Federal Ministry of Finance. Germany's tobacco tax base covers not only cigarettes and fine-cut tobacco but also heated tobacco and vaping liquids taxed as tobacco substitutes. The German Association of the Tobacco Industry and Novel Products, or BVTE, citing federal statistical data, said tax-paid cigarette volume fell 12.6% to 40.6 billion sticks. BVTE is using the latest figures to argue against further tax increases planned from 2027 through 2030, while Germany's parliament is scheduled to hold a first reading of the bill on September 24.
Sep.23
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09